News from cytosorbents corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Bloomberg:RTRKS,RICS:RTRKS)

Dec 18, 2014, 07:00 ET
CytoSorbents Logo.

CytoSorbents Receives NASDAQ Listing Approval

 CytoSorbents Corporation (OTCQB: CTSOD), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Dec 17, 2014, 11:34 ET

CytoSorbents kündigt strategische Partnerschaft mit Fresenius Medical Care an

 CytoSorbents Corporation (OTCQB: CTSOD), ein führendes Unternehmen auf den Gebieten Immuntherapie und Blutreinigung in der...

Dec 16, 2014, 21:55 ET

CytoSorbents conclut un partenariat stratégique avec Fresenius Medical Care

 CytoSorbents Corporation (OTCQB: CTSOD), leader dans le domaine de l'immunothérapie pour soins intensifs et de la purification du sang,...

Dec 16, 2014, 11:35 ET

CytoSorbents kondigt strategische samenwerking aan met Fresenius Medical Care

 CytoSorbents Corporation (OTCQB: CTSOD), een leider op het gebied van acute immunotherapie en bloedzuivering, kondigde gisteren een...

Dec 15, 2014, 11:15 ET
CytoSorbents Logo.

CytoSorbents Announces Strategic Partnership with Fresenius Medical Care

 CytoSorbents Corporation (OTCQB: CTSOD), a leader in critical care immunotherapy and blood purification, announced today that they have...

Dec 10, 2014, 09:25 ET
CytoSorbents Logo

Recent CytoSorb® Case Reports Highlight its Use to Help Save the Lives of Critically-Ill Patients

CytoSorbents Corporation (OTCQB: CTSO) trading under stock ticker symbol CTSOD, a critical care immunotherapy company commercializing its...

Dec 10, 2014, 09:10 ET
CytoSorbents Logo

Recent CytoSorb® Case Reports Highlight its Use to Help Save the Lives of Critically-Ill Patients

 CytoSorbents Corporation (OTCQB: CTSOD), a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber to treat...

Dec 05, 2014, 20:00 ET
CytoSorbents Logo.

CytoSorbents Reports Temporary Change of Stock Trading Symbol

CytoSorbents Corporation (OTCQB: CTSOD; OTCQB: CTSO), a critical care immunotherapy company specializing in blood purification to treat...

Dec 05, 2014, 15:37 ET
CytoSorbents Logo.

CytoSorbents Teams with Smart Medical Solutions to Distribute CytoSorb® in Romania and Moldova

 CytoSorbents Corporation (OTCQB: CTSO) (OTCQB: CTSOD), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal...

Nov 26, 2014, 09:00 ET
CytoSorbents Logo.

CytoSorbents to Host Second CytoSorb® Users Meeting and Symposium at the DIVI Critical Care Congress

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy  company commercializing its CytoSorb® cytokine adsorber to...

Nov 21, 2014, 09:00 ET
CytoSorbents Logo.

CytoSorbents Wins Beacon of Light Award

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb®...

Nov 14, 2014, 09:00 ET
CytoSorbents Logo.

CytoSorbents Announces Appointment of New Board Director

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber to treat...

Nov 12, 2014, 16:14 ET
CytoSorbents Logo.

CytoSorbents Achieves First $1M in Quarterly CytoSorb Sales in Q3 2014

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber to treat...

Nov 10, 2014, 07:00 ET
CytoSorbents Logo.

CytoSorbents Announces Initial Partnership with a Leading Global Cardiac Surgery Company

 CytoSorbents Corporation (OTCQB: CTSO), a blood purification company commercializing its CE Mark approved CytoSorb® extracorporeal...

Nov 06, 2014, 17:09 ET
CytoSorbents Logo

CytoSorbents Issues Shareholder Update Letter on Consent Solicitation Statement and Up-Listing Plans

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood...

Nov 05, 2014, 08:05 ET
CytoSorbents Logo

CytoSorbents to Report Q3 2014 Operating and Financial Results

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood...

Nov 03, 2014, 08:30 ET

Biocon Expands its Strategic Partnership with CytoSorbents for CytoSorb® to Treat SIRS and Cardiac Surgery Patients

 Biocon Ltd (BSE code: 532523, NSE: BIOCON),  Asia's premier biopharmaceuticals company, and U.S.-based CytoSorbents Corporation (OTCQB:...

Oct 14, 2014, 06:45 ET
CytoSorbents Logo

Preliminary Q3 2014 Report: CytoSorbents Achieves Its First Quarter of Approximately $1M in CytoSorb® Sales and Provides Up-listing Update

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood...

Oct 10, 2014, 06:00 ET
CytoSorbents Logo.  (PRNewsFoto/CytoSorbents)

CytoSorbents Wins 2014 GREAT Tech Award In Health

CytoSorbents Corporation (OTCQB: CTSO) is proud to announce that it was named the Health sector winner at the 2014 GREAT Tech Awards Gala last...

Oct 03, 2014, 07:00 ET
CytoSorbents Logo.  (PRNewsFoto/CytoSorbents)

CytoSorbents Launches International CytoSorb® Treatment Registry

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening conditions,...